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Objective: To characterize the changes in gut microbiota during pregnancy and
determine the effects of nutritional intervention on gut microbiota in women from subSaharan Africa (the Democratic Republic of the Congo, DRC), South Asia (India and
Pakistan), and Central America (Guatemala).
Methods: Pregnant women in the Women First (WF) Preconception Maternal Nutrition
Trial were included in this analysis. Participants were randomized to receive a lipidbased micronutrient supplement either ≥3 months before pregnancy (Arm 1); started the
same intervention late in the first trimester (Arm 2); or received no nutrition supplements
besides those self-administered or prescribed through local health services (Arm 3).
Stool and blood samples were collected during the first and third trimesters. Findings
presented here include fecal 16S rRNA gene-based profiling and systemic and intestinal
inflammatory biomarkers, including alpha (1)-acid glycoprotein (AGP), C-reactive protein
(CRP), fecal myeloperoxidase (MPO), and calprotectin.
Results: Stool samples were collected from 640 women (DRC, n = 157; India, n = 102;
Guatemala, n = 276; and Pakistan, n = 105). Gut microbial community structure did
not differ by intervention arm but changed significantly during pregnancy. Richness, a
measure of alpha-diversity, decreased over pregnancy. Community composition (betadiversity) also showed a significant change from first to third trimester in all four
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sites. Of the top 10 most abundant genera, unclassified Lachnospiraceae significantly
decreased in Guatemala and unclassified Ruminococcaceae significantly decreased in
Guatemala and DRC. The change in the overall community structure at the genus
level was associated with a decrease in the abundances of certain genera with low
heterogeneity among the four sites. Intervention arms were not significantly associated
with inflammatory biomarkers at 12 or 34 weeks. AGP significantly decreased from 12
to 34 weeks of pregnancy, whereas CRP, MPO, and calprotectin did not significantly
change over time. None of these biomarkers were significantly associated with the gut
microbiota diversity.
Conclusion: The longitudinal reduction of individual genera (both commensals and
potential pathogens) and alpha-diversity among all sites were consistent and suggested
that the effect of pregnancy on the maternal microbiota overrides other influencing
factors, such as nutrition intervention, geographical location, diet, race, and other
demographical variables.
Keywords: low middle income countries, gut microbiota, inflammation, pregnancy, small quantity lipid-based
nutrient supplements (SQ-LNS)

comprehensive and systematic assessments of gut microbiota
changes during pregnancy, particularly in low-resource settings
where data are lacking and health status, environment, and diet
may differ from high-resource settings, and in relation to other
health indicators that are reported to change over pregnancy,
such as inflammation.
The Women First (WF) Preconception Maternal Nutrition
Trial recruited women of reproductive age living in resourcelimited environments [Democratic Republic of the Congo
(DRC), India, Guatemala, and Pakistan] to participate in
a preconception lipid-based nutrient supplementation trial
(Hambidge et al., 2014). As part of the WF trial, biospecimens
for the gut microbiota and systemic and intestinal inflammation
were collected. Our previous report demonstrated distinctive
dietary intakes and gut microbiota between non-pregnant WF
participants in DRC and India prior to conception and initiation
of the intervention (Tang et al., 2019). This report aims
to determine the effect of pregnancy on the gut microbiota
diversity and composition and inflammatory biomarkers in WF
participants. We hypothesized that gut microbiota diversity and
composition change over the course of pregnancy from the
first to third trimester and would differ by intervention arm.
Since pregnancy is known to cause changes in inflammation,
we also examined potential associations between changes in gut
microbiota and changes in systemic and intestinal inflammatory
biomarkers during pregnancy.

INTRODUCTION
The gut microbiome plays a critical role in human health
and disease, including growth, body weight regulation, and
immune function (Turnbaugh et al., 2006, 2009), especially
during critical developmental phases. Pregnancy represents a
time of altered metabolism, insulin sensitivity, immune response,
and possibly the gut microbiota. Despite recent efforts and
progress in elucidating the role of gut microbiota in human
health and disease, there is a lack of consensus on changes in
the gut microbiota during pregnancy. More importantly, whether
this change is connected to metabolic health indicators, like
inflammatory biomarkers, is still unclear. A limited number of
studies have reported gut microbiota changes during pregnancy.
One study in Finland found an increase in the microbial counts
by qPCR from the first to third trimester (Collado et al., 2008).
A landmark study using the same cohort (Koren et al., 2012)
reported that while the gut microbiota in the first trimester
was comparable to pre-pregnancy microbiota, there was a
reduced diversity and increased abundance of pro-inflammatory
strains, such as Proteobacteria, in the third trimester. Of note,
participants in this study received probiotics and diet counseling
(Koren et al., 2012). Several studies were published after this,
producing inconsistent findings. Two studies on US women
showed that gut microbiota remained relatively stable throughout
pregnancy (DiGiulio et al., 2015; Dunlop et al., 2019). One Italian
cohort showed an increase in diversity when comparing the
second and third trimesters in women with gestational diabetes
(Ferrocino et al., 2018).
Overall, current literature is limited and inconclusive, with
different gut microbiota diversity and compositions. The
discrepancies observed among these studies could partially
be attributed to different analytical approaches, potential
confounding variables (health status, diet, and probiotic use), and
time of sample collection. These discrepancies warrant additional
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Study Design
The WF trial aimed to determine whether a preconception
nutrition supplement promotes better length and other
anthropometric outcomes at birth (Hambidge et al., 2019).
Women of child-bearing age were recruited from rural and
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pen, and a Styrofoam storage box containing ice or ice packs were
provided to each participant. The stool was collected into the fecal
bag using a sterile scoop and then placed into a second Ziploc
bag by participants. The bag was then placed into the Styrofoam
storage container until picked up by the research team on the
day the stool was passed. When receiving samples, the research
team labeled the sample date and time of stool passage. The
research team scooped about a teaspoon of stool and transferred
the sample to a sterile stool storage tube with 3 mL RNAlaterTM ,
ensuring that the specimen was coated with RNAlaterTM and that
the label was complete. The stool samples were then frozen at
–20◦ C or at a colder temperature. Samples were shipped to the
University of Colorado on ice packs or at ambient temperature.
Upon receipt, all samples were stored at –80◦ C until aliquoted
and analyzed. Some samples were initially stored at –20◦ C but
were transferred to permanent storage at –80◦ C. An additional
fecal sample was collected without RNAlaterTM for inflammatory
biomarker analysis; this sample was frozen at –80◦ C, shipped on
dry ice, and stored at –80◦ C at UCD until analysis.

semi-rural regions of DRC (Ubangi Province), Guatemala
(Chimaltenango), India (Belagavi, Karnataka), and Pakistan
(Thatta, Sindh Province). Enrolled participants were randomized
to one of the following three arms: (1) started the daily
supplement ≥3 months before conception and continued
through delivery (Arm 1); (2) started the same intervention
of daily supplement late in the first trimester until delivery
(Arm 2); or (3) received no nutrition supplements besides
those self-administered or prescribed through local health
services (Arm 3). The supplement was a small-quantity lipidbased micronutrient supplement (SQ-LNS) containing ∼20
micronutrients and a favorable mix of PUFAs (Hambidge et al.,
2019). Findings presented in the current report include the gut
microbiota data of women who were pregnant within 24 months
of enrollment. Stool and blood samples were collected from
the participants at the end of the first and during the third
trimesters. Participants in Arms 1 and 2 provided samples at
both time points, while participants in Arm 3 provided samples
at 34 weeks only. For the first trimester time point, specimens
were collected from participants in Arm 2 prior to initiating
the intervention supplement, and this group thus served as a
control group at 12 weeks. In India, the sampling site did not
collect samples from participants in Arm 3 at third trimester.
At the DRC site, the blood sample was not collected due to
a lack of cold chain facilities. Information on participants’
demographics, home environment, and family health history
was also collected at enrollment. The WF trial was registered at
clinicaltrials.gov (NCT01883193).

16S rRNA Gene Sequencing
Bacterial profiles were determined by broad-range amplification
and sequence analysis of the 16S rRNA gene following our
previously described methods (Hara et al., 2012; Markle
et al., 2013; Tang et al., 2017, 2019). In brief, amplicons
were generated using primers that target approximately 450
base pairs of the V3–V4 variable region of the 16S rRNA
gene (primers 338F: 50 ACTCCTACGGGAGGCAGCAG and
806R: 50 GGACTACHVGGGTWTCTAAT). PCR products were
normalized using a SequalPrepTM kit (Invitrogen, Carlsbad, CA,
United States), pooled, lyophilized, purified, and concentrated
using a DNA Clean and Concentrator Kit (Zymo, Irvine, CA,
United States). Pooled amplicons were quantified using Qubit
Fluorometer 2.0 (Invitrogen, Carlsbad, CA, United States).
Illumina paired-end sequencing was performed on the Miseq
platform with versions v2.4 of the Miseq Control Software and
MiSeq Reporter, using a 600 cycle version 3 reagent kit.
Illumina Miseq paired-end reads were aligned to human
reference genome hg19 with bowtie2, and matching sequences
were discarded (Homo Sapiens, 2009; Langmead and Salzberg,
2012). As previously described, the remaining non-human
paired-end sequences were sorted by sample via barcodes in
the paired reads with a python script (Tang et al., 2017, 2019).
The sorted paired reads were assembled using phrap (Ewing
et al., 1998; Ewing and Green, 1998). Pairs that did not assemble
were discarded. Assembled sequence ends were trimmed over
a moving window of five nucleotides until the average quality
was met or exceeded 20. Trimmed sequences with more than
one ambiguity or shorter than 350 nt were discarded. Potential
chimeras identified with Uchime (usearch6.0.203_i86linux32)
(Edgar et al., 2011) using the Schloss (Schloss and Westcott,
2011). Silva reference sequences were removed from the
subsequent analyses. Assembled sequences were aligned and
classified with SINA (1.3.0-r23838) (Pruesse et al., 2012) using the
418,497 bacterial sequences in Silva 115NR99 (Quast et al., 2013)
as reference configured to yield the Silva taxonomy. Operational

Participants
Women of child-bearing age were recruited from the four
sites based on the following inclusion criteria: age 16–35 years;
parity 0–5, with site-specific strategies to include nulliparous
participants; no current or planned contraceptive use; and
expectation to conceive during the following 18 months.
Informed consent was obtained from all participants. All
participants who entered the pregnancy phase of the study
consented to provide blood and fecal biospecimens. Hence, the
women in the current study were primarily those who were the
first to conceive.

Blood Sample Collection
Blood samples were collected at 12 weeks (Arms 1 and 2) and
at approximately 34 weeks (Arms 1, 2, and 3) of gestation.
Specimens were collected using Sarstedt blood collection SafetyMultifly needles and serum S-Monovette blood collection
tubes (Newton, NC, United States). The blood clotted for 30 min,
was centrifuged, and then transferred to cryovials (Sarstedt).
Serum was stored in –80◦ C freezers located at each site until
shipment on dry ice to the University of Colorado Pediatric
Nutrition Laboratory for analysis. Upon receipt, all samples were
stored at –80◦ C until aliquoted and analyzed.
R

R

Fecal Sample Collection
Two stool samples were collected from each participant during
pregnancy. A pre-labeled fecal bag, Ziploc bag, a black cryogenic

Frontiers in Microbiology | www.frontiersin.org

3

August 2022 | Volume 13 | Article 823757

Tang et al.

Gut Microbiota Change During Pregnancy

We used cold 1% v/v 100× protease inhibitors (Sigma-Aldrich,
St. Louis, MO, United States, catalog #P2714) in PBS (SigmaAldrich, St. Louis, MO, United States, catalog #P3813) as the
extraction buffer. For the detection of both calprotectin and
MPO, 5 mL of extraction buffer was added to 100 mg of stool,
and the sample was vortexed at 1,500 rpm for 30 min. Extracts
were then centrifuged at 3,000 g for 10 min at 4◦ C, then aliquoted,
snap-frozen, and stored at –80◦ C until analysis. The amount
of time between extraction and analysis was minimized and
consistent to minimize the confounding of stability issues (1 day
for MPO). To minimize the potential batch effects, samples were
balanced across runs by site, arm, and time point.

taxonomic units (OTUs) were produced by clustering sequences
with identical taxonomic assignments. The average Good’s index
of each sequence library was 99.7%, and the minimum Good’s
index was 99.0%, indicating that the most biodiversity was
captured in each library (participant) and the depth of sequencing
was sufficient to represent the biodiversity in the specimens.
A minimum read count of 3,700 was used to further filter
libraries. The median number of read counts across all the
samples was 96,064 with a minimum of 3,983, a maximum
of 406,259, and an IQR of 82,504. The software package
Explicet (v2.10.5) (Robertson et al., 2013) was used for display,
microbial diversity analysis, and figure generation of results.
The 16S rRNA gene sequence data and associated metadata
have been deposited in the NCBI Sequence Read Archive under
Bioproject ID PRJNA553183.

Statistical Approach
The longitudinal microbiome data were available for a subset of
mothers. The mean age and BMI of these mothers were compared
within each site to the mean age and BMI of all mothers from the
respective site. A difference of means t-test was used to determine
if these baseline characteristics were different among the two
groups. Likewise, the distributions of SES and maternal education
were compared at the site level between the two groups using the
Cochran–Armitage test.
Data presented here were analyzed cross-sectionally and
longitudinally. Analyses were performed stratified by the site
for both alpha- and beta-diversity, and individual OTUs and
results were combined using meta-analysis as described below.
Statistical analyses were completed at the genus level. Across
the entire dataset, OTUs present in at least 5% of all samples
and with a relative abundance greater than 0.001 in at least
one sample were retained for analysis. Microbiome information
for the control arm (Arm 3) was not collected at 12 weeks of
gestation. As a result, analyses comparing mothers across arm
status could not be conducted. Instead, an intervention arm in
the form of supplemental status at each time point was used to
investigate the relationship between nutritional supplements and
the microbiome. In this way, mothers from Arm 2 served as a
control group at 12 weeks of gestation allowing for meaningful
statistical comparisons. To be clear on how supplement status
was assigned, at 12 weeks, women in Arm 1 had supplement
status equal to 1, and women in Arm 2 had supplement status
equal to 0. At 34 weeks, women in Arms 1 and 2 had supplement
status equal to 1, and women in Arm 3 had supplement status
equal to 0. When possible, we tested the interaction between
supplement status and time. There were no samples from women
in Arm 3 for India, thus it was not possible to test for the
interaction between supplement and time for this site at 34 weeks
of gestation. Given the assumption of no interaction, we were able
to test for association between the microbiome and supplement
and between the microbiome and time. All models included
standardized read depth and batch as covariates.
Generalized estimating equations (GEEs) were used to model
the association between time and supplement status and the
interaction between time and supplement and four measures
of alpha-diversity (Sobs, Chao 1, Shannon H, and Shannon
H/Hmax) when controlling for site-specific covariates and
repeated measures over individuals. PERMANOVA using 1,000
permutations with adjustments for repeated measures was used

Inflammatory Biomarker Analyses
Inflammatory biomarkers in the blood (AGP and CRP) and
feces (MPO and calprotectin) were analyzed. C-reactive
protein (CRP) was measured in serum samples from
Guatemala and Pakistan using a sandwich immunoassay
with electrochemiluminescent detection (Meso Scale Discovery,
Gaithersburg, MD, United States, catalog #K151STD). The
limit of detection was 0.034 mg/L, and within-day and
between-day precisions were 5 and 6.4%, respectively.
Samples from India were analyzed by immunoturbimetry
(Siemens Dimension, Malvern, PA, United States) at the KLE
Hospital Clinical Lab (Belagavi, Karnataka, India). The limit
of detection was 0.6 mg/L, with a within-day precision of
1.1% and the between-day precision of 1.4%. Serum α-1-acid
glycoprotein (AGP) was measured using a sandwich enzymelinked immunoassay (R&D Systems, Bio-Techne Corporation,
Minneapolis, MN, United States, catalog #DAGP00). For
samples from Guatemala and Pakistan, the limit of detection
was 0.001 µg/mL, and the within-day and between-day
precisions were 4.8 and 14.2%, respectively. The limit of
detection of the method used in India was 0.002 µg/mL,
while the within-day sensitivity was 7.5% and the between-day
sensitivity was 10.7%. To minimize potential batch effects,
samples from Guatemala and Pakistan were balanced across
runs by randomizing within the site, arm, and longitudinal
time points in Excel. Samples from India were not randomized
but instead run chronologically by participant ID, starting
with 12-week and then 34-week time points. The study design,
however, randomized participant ID across arms, which
minimized batch effects.
The levels of calprotectin and myeloperoxidase were measured
in the fecal samples. Calprotectin was measured using a two-step
sandwich enzyme-linked immunoassay (ALPCO, Salem, NH,
United States, catalog #30-CALPHU-EO1) without changes in
the protocol. The within-day and between-day precisions were
4.6 and 12%, respectively. The limit of detection was 1.8 ng/mL.
Myeloperoxidase was measured using a sandwich immunoassay
with electrochemiluminescent detection (Meso Scale Discovery,
Gaithersburg, MD, United States, catalog # K151EE), with the
limit of detection of the method being 0.03 ng/mL, withinday precision being 4.5%, and between-day precision being 9%.
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alpha-diversity measures, a random-effects meta-analysis was
performed with an interaction between time and supplement, as
well as for time and supplement terms without the interaction
term included in the model. India was not included in this metaanalysis due to all women being on the supplement at 34 weeks.
All random-effects meta-analyses were performed using the
metagen function from the meta R package (Balduzzi et al., 2019).
Meta-analysis for beta-diversity was performed using Fisher’s
combination of p-values for the interaction term, as well as time
and supplement with the interaction term removed. Forest plots
were created for all OTUs and alpha-diversity meta-analyses
using the forest function from the meta R package.
The differences in the relative abundance of the four
most abundant phyla with respect to site location (the DRC,
Guatemala, India, and Pakistan) and time (12 weeks of gestation
compared to 34 weeks of gestation) are analyzed on the complete
dataset (all site locations combined). All models at this taxonomic
level are conditioned on the batch in which samples were
analyzed, but no other covariates are used for adjustments. Two
linear mixed-effects models are constructed for each phylum: one
to fit the relationship of relative abundance with the interaction
of time and site, the other to fit the relationship of relative
abundance with time and site without considering the interaction
of the two. ANOVA on the mixed-effects models is used to assess
the strength of the association between the relative abundance
and the factor of interest, starting with the interaction model
and then moving to the additive model if the p-value for
interaction is not below a threshold of 0.05. If the interaction
has a strong association with relative abundance, t-tests for
pairwise comparisons of the factor levels are performed and
p-values are adjusted using Tukey’s adjustment. If the interaction
was not strongly associated but one, or both, of the additive
factors are strongly associated (i.e., P < 0.05) with the relative
abundance, then the pairwise comparisons are performed using
the additive model.

to assess the association of time or supplement status with
beta-diversity controlling for site-specific covariates using the
Bray-Curtis metric.
Individual OTUs were regressed on time and supplement
status controlling for site-specific covariates using a negative
binomial generalized linear model. Significance testing was
performed by using 1,000 bootstrap samples to generate the
distribution for effect estimates and then testing the hypothesis
that the mean was equal to zero. The code used for this analysis is
available on GitHub and can be accessed through the URL in the
resources section.
As there were too many possible covariates to include for
stable models and to account for differences between countries,
we selected site-specific covariates as follows. Ninety-eight
putative covariates were considered. Each covariate was assessed
separately for each site and timepoint by using PERMANOVA to
model beta-diversity as the outcome and the putative covariate
of interest as a predictor. Each model was also adjusted for
batch, regional cluster, and supplement status by including
these parameters in the model. For each site, if the association
between the covariate and beta-diversity had a p-value below
0.1 for at least one time point, it was considered further. The
pairwise Pearson correlation for these putative covariates was
then estimated within each site to avoid collinearity issues in
the final models. Only one covariate was retained from covariate
pairs with a correlation greater than 0.7. Within each pair,
the putative covariate associated with most sites was kept. If
the putative covariates were associated in the same number of
sites, we considered whether the highly correlated covariates
represented similar characteristics and selected the covariate that
was more general (e.g., overall SES was kept instead of a single
SES factor) to make our final list of covariates. Table 1 provides
a summary of all covariates used in the final multivariable
models by the site.
To control for multiple testing, p-values were adjusted
within site and analysis type (alpha-diversity, beta-diversity,
or individual OTU) using the Benjamini–Hochberg method to
control the false discovery rate (FDR) at 0.05 (Benjamini and
Hochberg, 1995). All statistical analyses were performed using
R version 4.0.3.
Meta-analyses across the four sites were performed at the
genus level for individual OTUs, as well as alpha- and betadiversity measures. Random-effects meta-analysis was performed
for time and supplement terms for each OTU. For the four

RESULTS
Participants and Biospecimens
The recruitment of participants took place between December
2013 and October 2014. Out of the 3,251 participants who entered
phase 2 (pregnancy) of the WF trial, stool samples were collected
from 640 participants. These 640 participants were those who
consented to biospecimen collection and were representative of
the WF cohort. Table 2 summarizes the number of stool samples
that were collected from the WF participants at 12 and 34 weeks
of pregnancy. At 12 weeks, stool samples were collected from
women in Arms 1 and 2 (prior to initiation of supplement).
At 34 weeks, samples were collected from all three arms at
all sites except for India, where samples were collected from
Arms 1 and 2 only. Participants’ baseline age, BMI, education,
and SES indicators are summarized in Table 3. Overall, the
subcohort of WF participants in which gut microbiota was
profiled was representative of the parent cohort (Hambidge et al.,
2019). Comparing the included (women with microbiota data)
vs. excluded (women without microbiota data), three variables at

TABLE 1 | List of covariates used in all final models by the site.
DRC

Guatemala

India

Pakistan

Batch

X

X

X

X

Read depth

X

X

X

X

Overall SES

X

Improved water source

X

Delivery date

X

Total years of schooling (mother)

X

Supplement compliance
Cooking fuel
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was evidence of a consistent lower overall diversity (Shannon
H diversity index) in women taking the nutritional supplement
compared to women not taking the supplement (meta-analysis
estimate of –0.08 and meta-analysis FDR-adjusted p-value of
0.0276). Additionally, there was evidence for a consistent
decrease in the Shannon H diversity from 12 to 34 weeks of
gestation (meta-analysis estimate of –0.22 and meta-analysis
FDR-adjusted p-value of 0.0197). In the stratified analysis of the
Guatemalan cohort, there was strong evidence to conclude that
richness, evenness, and overall diversity decreased from 12 to
34 weeks of gestation (richness estimate = –2.13, P = 0.0216;
evenness estimate = –0.04, P = 0.0002; overall estimate = –0.25,
P = 0.0002) (Figure 1). To summarize, women on supplements
tended to have lower diversity (Shannon H) than women
who were not on the supplement; from 12 to 34 weeks, gut
microbiota diversity (Shannon H) tended to decrease. The
strength of the relationship, however, was not always consistent
across the four sites.
Beta-diversity values between observations from the same
time point (12 weeks of gestation compared to 34 weeks of
gestation) were more similar than the values between the time
points in all four sites [DRC (P = 0.0009), Pakistan (P = 0.0009),
Guatemala (P = 0.0009), and India (P = 0.034)]. Additionally,
beta-diversity was seen to have a significant association with the
supplement status in DRC (P = 0.003) and Pakistan (0.0009).
However, there was insufficient evidence to conclude that the
interaction between time and supplement status is associated
with beta-diversity in any of the sites. These results are better
understood through a PCoA plot (Figure 2) that visualizes
the first two principal coordinate axes that are constructed
using observations from all four sites and then colored by
species evenness (Shannon E). PCoAs 1 and 2 contributed to
roughly 4% of the overall variability, which is a relatively low
percentage of total variability and indicates it will be difficult to
project relationships within the data to a two-dimensional figure.
However, it appears that PCoA axis 1 separates observations by
alpha-diversity, with smaller values on the left and larger values
on the right. Because evenness was associated with supplement
and time, it is reasonable to conclude that the beta-diversity
results and the alpha-diversity results are being driven by the
same underlying taxa.

TABLE 2 | Number of microbiota samples analyzed by site, gestational time
points, and supplement arms.
First trimester
(12 weeks)

Third
trimester
(34 weeks)

Total number of
participantsa

Arms

1

2

1

2

3

DRCb

46

45

48

40

54

157

Guatemala

94

98

85

95

76

102

India

49

48

48

46

0

276

Pakistan

35

28

36

27

34

105

Total samples

224

219

217

208

164

640

a Total

number of participants that completed both first and third trimester
sample collections.
b DRC, the Democratic Republic of the Congo.

TABLE 3 | Participants’ baseline characteristics by site.
DRC#

India

Guatemala

Pakistan

Age, y*

24 ± 5
(0.58)

22 ± 3
(0.40)

24 ± 4
(0.24)

22 ± 4
(0.54)

BMI (kg/m2 )*

20 ± 2
(0.64)

19± 3
(0.01)

25± 4
(0.49)

20 ± 3
(0.63)

Maternal education
(P-value)

(0.84)

(0.002)

(0.69)

(0.81)

No school (n)

35

1

17

90

Primary (n)

92

11

188

10

Secondary or more
(n)

27

90

71

5

Tally of indicators of
higher SES
(P-value)

(0.38)

(0.79)

(0.69)

(0.01)

None (n)

76

0

0

2

1–2 (n)

76

13

30

36

3–4 (n)

2

63

161

39

5–6 (n)

0

26

85

28

4.7 (1.2)

6.2 (0.7)

7.8 (0.9)

6.5 (1.5)

GWG (kg)&
# DRC,

the Democratic Republic of the Congo; SES, Socio-economic status.
± SD (P-value). P-values were for the comparisons of women with
microbiota samples vs. all women from that site.
& Gestational weight gain from first to third trimester.
∗ Mean

two sites were significantly different at a nominal 0.05 level: BMI
in India (19.3 included vs. 20.2 excluded, P = 0.01), SES indicator
in Pakistan (median 3 for included vs. median 2 for excluded,
P = 0.01), and maternal education in India (median 3 for included
vs. median 2 for excluded, P = 0.002).

Gut Microbiota Community Structure
The top four most abundant phyla, accounting for >95% of
sequences, were Firmicutes, Bacteroidetes, Proteobacteria, and
Actinobacteria for all four sites at both time points in pregnancy
(Table 4). Relative abundances at the genus level are summarized
in Supplementary Figure 1. Among the most abundant genera,
there were no statistically significant relationships between taxa
count and supplement status or time point after adjusting
for multiple testing, which was consistent in all four sites.
In the stratified analyses, unclassified Ruminococcaceae showed
a significant decrease in abundance during pregnancy in
DRC (estimate = –0.442, FDR P = 0.0003) and Guatemala
(estimate = –0.389, FDR P = 0.00002). Prevotella and unclassified
Lachnospiraceae were also significantly associated with time
in the Guatemala cohort: Prevotella increased from 12 to

Diversity of Gut Microbiota
Alpha-diversity was evaluated in terms of both richness (Chao1,
the number of OTUs predicted based on observed singletons and
doubletons), evenness (Shannon H/Hmax), and overall diversity
of richness and evenness combined (Shannon H diversity index).
Overall, there was insufficient evidence to conclude women
taking the nutritional supplement had a different trend in alphadiversity from 12 to 34 weeks than the control group (metaanalysis FDR-adjusted p-values of 0.289, 0.688, and 0.603 for
richness, evenness, and overall diversity, respectively). There
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FIGURE 1 | Adjusted mean estimate for alpha-diversity values by site and time (12 vs. 34 weeks). Each panel represents one pairing of site and alpha-diversity
measure [eveness, richness, and Shannon diversity (richness and eveness)]. Each value is the adjusted mean estimate from the GEE model (diamond point) and
95% CI (error bars) for the respective measure of alpha-diversity split by time point and supplement status. Supplement status “Yes” indicates Arm 1 at 12 weeks
and Arms 1+2 at 34 weeks. Supplement status “No” indicates Arm 2 at 12 weeks and Arm 3 at 34 weeks. The corresponding p-values for tests of time and
supplement status are overlayed in the top-right corner of each panel.

34 weeks (estimate = 0.326, FDR P = 0.000005) and unclassified
Lachnospiraceae decreased from 12 to 34 weeks (estimate = –
0.236, FDR P = 0.0165). Among the top 10 most abundant
genera, there was not enough evidence to conclude an association
between abundance and supplement status in the stratified
analyses. A broader, genus-level analysis showed numerous
genera that significantly (FDR P < 0.05) changed in relative
abundance from the first to third trimester (Supplementary
Table 1) or changed by supplement status (Supplementary
Table 2) in at least one site. A meta-analysis of all sites combined
was conducted at the broader genus level, and the results of
significant changes are summarized in Table 5. These results
show a decrease in the abundances of certain genera with
consistent significant effects observed among the four sites.

collected. Inflammatory markers were not measured in the
DRC due to limited access to the cold chain facility. Table 6
presents these inflammatory biomarkers by site and stage of
pregnancy. Supplement status did not significantly affect the
inflammatory biomarkers. AGP significantly decreased from 12
to 34 weeks of pregnancy and other inflammatory biomarkers
did not significantly differ over pregnancy. These biomarkers
were not significantly associated with the alpha-diversity values
of gut microbiota.

DISCUSSION
The extent to which gut microbiota changes during pregnancy
remains an open question, and most existing studies have been
conducted in high-resource settings. Our study included lowresource settings in four countries with distinctive cultural
and dietary backgrounds (Tang et al., 2019). For example,
the communities within the DRC site predominantly included

Inflammation During Pregnancy
The inflammatory biomarkers in the blood (AGP and CRP) and
stool [myeloperoxidase (MPO) and calprotectin] were analyzed
in a subgroup of participants from whom stool samples were
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FIGURE 2 | Bray-Curtis PCoA plot of all sites and timepoints colored by Shannon H index. PCoA1 shows a separation of observations based upon a measure of
eveness. The percentage of variance explained by each axis is presented in parentheses within the figure legends. Together, the first two components explain just
under 4% of the variation in the Bray-Curtis metric.
TABLE 4 | The top four most abundant phyla at the first and third trimesters by the sitea,d .
DRCb

Phyla

Guatb

India

Pakistan

Firstc

Thirdc

First

Third

First

Third

First

Third

Firmicutese

56% (17.9%)

55% (17.9%)

56% (13.8%)

49% (15.2%)

53% (14.4%)

48% (14.7%)

54% (17.4%)

47% (16.4%)

Bacteroidetesf,g

27% (17.1%)

31% (18.3%)

32% (14.3%)

40% (16.6%)

28% (14.8%)

31% (16.2%)

29% (18.0%)

38% (20.0%)

Actinobacteriag

2% (10.7%)

2% (7.6%)

1% (2.2%)

2% (3.9%)

6% (7.6%)

8% (12.6%)

7% (9.1%)

5% (10.2%)

Proteobacteriae

9% (11.6%)

9% (10.4%)

6% (6.9%)

5% (5.6%)

9% (8.6%)

10% (9.6%)

7% (10.0%)

7% (7.1%)

a Values

are average relative abundance (standard error).
the Democratic Republic of the Congo; Guat, Guatemala.
c First, first trimester (12 weeks); third, third trimester (34 weeks).
d ANOVA tests for significant factor levels in supplementary Table 3.
e Interaction between site and time is statistically significant; comparisons in Supplementary Tables 4, 5.
f Trimester is statistically significant; comparisons in Supplementary Table 6.
g Site is statistically significant; comparisons in Supplementary Tables 7, 8.
b DRC,

rural participants with a very low SES status compared to
the other sites. In addition, most participants from India
followed a lacto-vegetarian diet, whereas participants in other
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countries were more likely to consume some animal-sourced
foods. We previously reported distinct gut microbiota diversity
and composition between WF participants in DRC and India
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is associated with increased fat storage and insulin resistance,
which is considered beneficial for fetal growth and subsequent
lactation (Koren et al., 2012). In other words, the decreased alphadiversity during pregnancy may be a physiological adaptation.
The reasons for these discrepant observations among cohorts are
not clear, but these studies did differ in sample size, geographical
location, and maternal diets. The significant meta-analysis of
alpha-diversity in the present study was driven primarily by the
site in Guatemala as shown in the stratified analysis (Figure 1),
although the other three sites followed the same trend. This could
be due to the Guatemala cohort having the largest sample size
resulting in a smaller standard error of the estimate. The women
in the Guatemala site also had significantly higher BMI and the
lowest risk of being underweight compared to the other three
sites. It is probable that this physiological adaptation of a decrease
in alpha-diversity only occurs in the context of adequate energy
intake during pregnancy (e.g., Guatemala vs. the other three
sites). The dietary assessment did show that women from the
Guatemalan site had a greater energy intake (Lander et al., 2019).
Two published studies examined the gut microbiota change from
the second to the third trimester. In Tanzanian women, gut
microbiota remained stable from the second to third trimester
and was not affected by the consumption of probiotics in the form
of yogurt (Bisanz et al., 2015). In contrast, Italian women with
gestational diabetes (GDM) had an increase in alpha-diversity
from the second to third trimester (Ferrocino et al., 2018). Thus,
gut microbiota during pregnancy may change differently with
different maternal metabolic health statuses.
It is also important to consider potentially masked effects
due to outliers within the data studied in this manuscript.
All reported results come from statistical models fit using
site-stratified observations after performing microbiome quality
checks. For alpha-diversity, sensitivity analysis of the model
was performed by removing outliers defined as a residual value
below Q1 − 3∗ IQR or aboveQ3 + 3∗ IQR where Q1 is the 25th
percentile of the residuals, Q3 is the 75th percentile of the
residuals, and IQR is the inter-quartile range (Q3 − Q1 ) of the
residuals. After removing outliers, results were consistent in all
sites except for the DRC where there was evidence for changes
over pregnancy in several measures when outliers were removed
but not when outliers were included: Chao 1 (full = –2.09
and FDR-adjusted p = 0.218, outliers removed = –3.55 and
FDR-adjusted p = 0.0126), Shannon H/Hmax (full = –0.021
and FDR-adjusted p = 0.0712, outliers removed = –0.024 and

TABLE 5 | Meta-analysis of all sites combined for the genera remained significant.
Genera

Average relative
abundances

Meta-analysis
effect

Standard
error

FDR
P-value

Christensenellaceae

0.933%

–0.7

0.02

0.0064

VadinHA64

0.012%

–1.39

0.04

0.0116

Enterococcaceae

0.001%

–1.98

0.07

0.015

at enrollment before conception and prior to nutritional
intervention. At the baseline/enrollment visit, differences in
microbiota were associated with a complex set of environmental
factors, dietary patterns, nutritional status, and race/ethnicity
(Tang et al., 2019). Dietary intakes reported in the previous
analysis (Tang et al., 2019) were assessed during the first
trimester of the WF participants and showed different food
groups and nutrient intakes between women from the DRC and
India that were associated with differences in gut microbiota.
A subsequent report of all four sites also showed that dietary
patterns (exclusive of LNS supplements) varied widely among
sites but were uniformly lacking in multiple essential nutrients,
such as folate, vitamin B12, and choline (Lander et al., 2019). In
our current analysis of gut microbiota changes during pregnancy,
despite the differences in diet and other demographical factors, a
conserved shift in both diversity and community compositions
was observed among the four sites from the first to third
trimester. These changes were mostly consistent among the four
sites. These findings suggest that there may be consistent overall
effects of pregnancy on the gut microbiota that persist even
in the context of different cultural and dietary backgrounds or
supplementation with LNS.
Alpha-diversity values, as assessed by the Shannon H index,
showed a statistically significant decline from the first to third
trimester across all the study sites. Earlier research has been
inconsistent regarding alpha-diversity changes during pregnancy.
A Finnish cohort showed a significant reduction in richness from
the first to the third trimester (Koren et al., 2012). However, most
of the subsequent studies did not observe the same reduction
in microbial richness. Three US (DiGiulio et al., 2015; Dunlop
et al., 2019; Ruebel et al., 2021) and one Chinese (Yang et al.,
2020) cohort showed that microbial diversity remained stable
during pregnancy from the first to the third trimester. A concept
proposed on the basis of the Finnish cohort findings is that the
decreased gut microbiota diversity over the period of pregnancy

TABLE 6 | AGP, CRP, MPO, and calprotectin in first and third trimester by the sitea .
Site (sample size)

AGPb (µg/mL)
CRP (mg/L)
MPO (ng/mL)
Calprotectin (µg/g)
a Mean

First trimester (12 weeks)

Third trimester (34 weeks)

Pakistan (59)

India (97)

Guatemala (143)

Pakistan (86)

India (94)

Guatemala (200)

871 ± 305

990 ± 371

915 ± 362

565 ± 198

597 ± 243

643 ± 220

7.2 ± 24

6.2 ± 13

9.8 ± 11

5.0 ± 6

5.6 ± 8

11.1 ± 16

1,020 ± 2,607

1,112 ± 1,608

2,615 ± 4,481

1,306 ± 5,073

754 ± 1,789

2,091 ± 3,838

27 ± 57

45 ± 57

81 ± 116

34 ± 59

40 ± 78

60 ± 67

± SD. AGP, alpha (1)-acid glycoprotein; CRP, C-reactive protein; MPO, myeloperoxidase.
change over time (P = 0.0003).

b Significant
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FDR-adjusted p = 0.0248). This finding suggests that outliers
in the DRC cohort may be masking the association between
alpha-diversity and weeks of pregnancy (gestation). The decline
in alpha-diversity between the first and third trimesters was
consistent with the overall decrease in the abundance of several
genera (Table 1).
Consistent with our findings at the sites in DRC and India
before pregnancy (Tang et al., 2019), Prevotella remained the
most abundant genus among all sites during pregnancy, reflecting
the semi-rural setting and diets, and increased in Guatemala
over the course of pregnancy. Out of the top 10 most abundant
genera, unclassified Lachnospiraceae and Ruminococcaceae were
significantly diminished in relative abundance from the first
to the third trimester in Guatemala and DRC. These findings
are consistent with the Finnish cohort, which also showed a
decline in unclassified Lachnospiraceae and Ruminococcaceae
(Koren et al., 2012), and the Chinese cohort showed a decline
in unclassified Lachnospiraceae (Yang et al., 2020). Many
species of Ruminococcaceae and Lachnospiraceae families degrade
polysaccharides and produce short-chain fatty acids (SCFAs),
which are a key source of nutrients to the host (Magne et al.,
2006) and can directly regulate fat accumulation and energy
expenditure of the host (Kimura et al., 2014). The population
of Ruminococcaceae was reduced during the first trimester in
women with hyperglycemia compared with women with normal
glucose control in 50 Chinese women (Gao et al., 2020). In
contrast, the abundance of the Ruminococcaceae family was
associated with higher odds of a positive GDM diagnosis
in 75 Finnish women (Mokkala et al., 2017). Nevertheless,
the Ruminococcaceae family may be important in maintaining
a healthy metabolic profile during pregnancy. In our metaanalysis, unclassified Ruminococcaceae had a moderately strong
association with time based on the FDR P-value (P = 0.07).
Further investigation is needed to identify the unclassified
genera in the Ruminococcaceae and Lachnospiraceae families that
decreased during pregnancy.
Another genus, Blautia, a probiotic and SCFA producer, also
decreased in Guatemalan participants during pregnancy. In the
Italian GDM cohort, both Blautia and Lachnospiraceae increased
from the second to third third trimester (Ferrocino et al., 2018).
In the Chinese cohort (Yang et al., 2020), Blautia was also
enriched in women with GDM vs. without GDM. Two recent
studies (Ye et al., 2019; Soderborg et al., 2020) also showed that
Blautia was higher in women with GDM compared with nonGDM women, although the literature is not consistent. These
changes, together with those observed in Ruminococcaceae and
Lachnospiraceae in Guatemala, suggest that these putative SCFAproducing bacteria may be related to glycemic control during
pregnancy, and a reduction in abundance might be beneficial for
glucose regulation. In the WF participants, who on average had
relatively low gestational weight gain and BMI (Bauserman et al.,
2021), these genera decreased during pregnancy. Future research,
for example, utilizing germ-free mice, is needed to explore the
potential causal relation between these SCFA producers and
glycemic control during pregnancy.
During late pregnancy, pro-inflammatory cytokines may
increase (Kirwan et al., 2002) and insulin resistance may increase
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(Dahlgren, 2006). These metabolic changes are considered
normal and help in maintaining a sufficient nutrient supply
to the fetus. The Finnish cohort showed that a decreased gut
microbiota richness was associated with low-grade inflammation
during the third trimester (Koren et al., 2012). In the present
study, we saw a decrease in AGP concentration among all sites.
This is in contrast to previous findings and might be partially
due to the very large variance observed in the inflammatory
biomarkers (per timepoint per site) or an effect of hemodilution
on pregnancy. CRP, on average, was elevated among all sites
during pregnancy but did not change over time. Our values
were similar to a previous study reporting CRP at 24 weeks of
pregnancy in Denmark (Fink et al., 2019). The effects of maternal
intestinal inflammation and its relationship to the microbiota
during pregnancy, particularly in women in LMIC, warrant
systematic investigations.
The strengths of this study include longitudinal assessment
of gut microbiota during pregnancy (first and third trimester);
inclusion of a relatively large sample size from four different
countries across Africa, Asia, and Central America; and
comprehensive analysis of covariates, including the LNS
nutrition intervention of the primary trial. Limitations include
lack of control arm for the site in India at 34 weeks of
gestation; lack of blood from the DRC site; and only two time
points of assessment.
In summary, the longitudinal reduction of individual genera
(both commensals and potential pathogens) and alpha-diversity
were consistent among all sites and suggests that the effect
of pregnancy on the maternal microbiota overrides other
influencing factors, such as geographical location, diet and
nutrition supplement, race, and other demographical variables.
Future research is needed to explore the associations of gut
microbiota with other health indicators during pregnancy and
in the offspring.
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